Q&A · ESMA
Inducements
Answered
Read the official text on the ESMA website(opens in a new tab)AI-generated Summary
Arranging meetings with corporate issuers ('corporate access') is not research and cannot be paid from a research payment account; it is a separate service, and independent advisers and portfolio managers must assess whether it is a material benefit or an acceptable minor non-monetary benefit.
Details
| Reference | ESMA_QA_1795 |
|---|---|
| Issuer | ESMA |
| Published | 4 Apr 2017 |
| Answered | 4 Apr 2017 |
| Submitted | 4 Apr 2017 |
| ESMA topics | Inducements (research) |
| Earlier Q&A document | ESMA 35-43349 MiFID II Q&As on Investor protection Ch. 7, question 7 |
Provisions it relates to
- Article 24 MiFID II · General principles and information to clientsInferred · 90%
- MiFID II (whole act)Explicit reference